Topical Treatment for Pemphigus Vulgaris
For localized oral or skin lesions in pemphigus vulgaris, use topical corticosteroids as first-line therapy: clobetasol 0.05% ointment mixed in 50% Orabase applied twice weekly to localized oral lesions on dried mucosa, or betamethasone sodium phosphate 0.5 mg dissolved in 10 mL water as a rinse-and-spit mouthwash 1-4 times daily for more diffuse oral involvement. 1
Topical Corticosteroids: Primary Options
The British Association of Dermatologists 2017 guidelines provide specific formulations for topical management 1:
For Localized Oral Lesions:
- Clobetasol 0.05% ointment mixed in 50% Orabase: Apply twice weekly to localized lesions on dried mucosa. The patient can mix this at home and store in the refrigerator 1
- This is the most potent option for discrete, accessible lesions
For Diffuse Oral Involvement:
- Betamethasone sodium phosphate 0.5 mg in 10 mL water: Use as 2-3 minute rinse-and-spit solution 1-4 times daily 1
- Fluticasone propionate nasules diluted in 10 mL water: Use twice daily 1
For Skin Lesions:
- High-potency topical corticosteroids can be applied directly to cutaneous lesions 1
- Case reports demonstrate complete remission with topical steroids alone for localized cutaneous disease 2
Alternative Topical Agents
Tacrolimus 0.1% Ointment
Tacrolimus is equally effective to triamcinolone acetonide 0.1% paste for oral lesions, with both significantly reducing mucosal involvement and pain scores 1. Apply twice daily for 4 weeks. A split-mouth randomized trial (n=15) showed no difference between these agents 1. Consider tacrolimus when corticosteroid side effects are a concern or for recalcitrant lip lesions 1.
Topical Ciclosporin
Reserve for recalcitrant cases unresponsive to conventional topical treatment 1. Use 5 mL of 500 mg oral suspension three times daily for 2 months, or ciclosporin mouthwash (100 mg/mL) 5 mL three times daily 1. Small case series show 67% improvement rate (2 of 3 patients) 1. Major limitation: unpleasant taste and high cost 1.
Intralesional Triamcinolone Acetonide
For persistent localized lesions, perilesional/intralesional injections may shorten time to remission (126 vs 153 days, though not statistically significant) 1, 3. One case report showed sustained 18-month remission with injections at 3-week intervals for 3 months 3.
Clinical Algorithm for Topical Selection
Mild disease confined to oral mucosa: Start with clobetasol 0.05% in Orabase for localized lesions OR betamethasone mouthwash for diffuse involvement 1, 4
Localized skin lesions: Apply high-potency topical corticosteroids directly 2
Inadequate response after 4-6 weeks: Add tacrolimus 0.1% ointment twice daily 1
Recalcitrant localized lesions: Consider intralesional triamcinolone 3
Failure of above measures: Trial topical ciclosporin (if cost acceptable) 1
Important Caveats
Topical therapy alone is appropriate ONLY for mild, localized disease 1. Most patients require concomitant systemic therapy, and evidence for additional benefit of topicals is poor when used adjunctively 1. However, multiple case reports demonstrate successful monotherapy with topical corticosteroids for localized disease 2, 4.
Critical warning: Even when oral lesions respond to topical therapy alone, persistently elevated anti-desmoglein 3 antibodies may lead to "epitope spreading" and subsequent skin involvement 5. One case showed progression from mucosal to mucocutaneous disease after 26 months of topical-only management despite initial good control 5. Consider ELISA monitoring and systemic therapy if antibody titers remain elevated 5.
Adjunctive Measures
- Barrier preparations (Gengigel mouth rinse/gel or Gelclair) help with pain control 1
- Dilute mouthwashes by 50% if they cause excessive discomfort 1
- Bland emollients (50% white soft paraffin and 50% liquid paraffin) support barrier function for skin lesions 1
- Maintain good oral hygiene despite pain to prevent plaque accumulation 1